Literature DB >> 8223964

Improvement by diazepam of neuromuscular transmission blocked by anticholinesterase agents in mouse diaphragms.

L C Chiou1, C C Chang.   

Abstract

Effects of diazepam on the neuromuscular transmission blocked by neostigmine were studied in isolated mouse phrenic nerve-diaphragm preparations. Diazepam, in the absence of neostigmine, had no significant effect on the neuromuscular transmission at concentrations lower than 100 microM, except to enhance muscle contractility. Single and train pulses-evoked endplate potentials (e.p.p.s) and miniature e.p.p.s (m.e.p.p.s) were also unaffected. At concentrations of 175 microM or higher, diazepam caused an axonal conduction block. However, neostigmine-induced twitch potentiation, spontaneous fasciculation and tetanic fade were antagonized by diazepam at 3.5-35 microM. Diazepam did not decrease the amplitude of neostigmine-augmented e.p.p.s and m.e.p.p.s but slightly reduced their decay time. The incidence of regenerative depolarization of endplates induced by repetitive stimulation in the presence of neostigmine, was decreased from 92% to 35% junctions and the duration shortened from 650 ms to 230 ms. The amplitude of train e.p.p.s was increased. It is suggested that diazepam reverses the muscle paralysis induced by anticholinesterase agents by inhibiting the regenerative release of acetylcholine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223964     DOI: 10.1016/0926-6917(93)90041-n

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Enhancement by benzodiazepines of the inhibitory effect of adenosine on skeletal neuromuscular transmission.

Authors:  L C Chiou; J Y Ling; C C Chang
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

2.  Pharmacological relevance of peripheral type benzodiazepine receptors on motor nerve and skeletal muscle.

Authors:  L C Chiou; C C Chang
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.